These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma. Raue F; Frank-Raue K Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384 [TBL] [Abstract][Full Text] [Related]
65. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143 [TBL] [Abstract][Full Text] [Related]
66. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E; Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685 [TBL] [Abstract][Full Text] [Related]
67. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905 [TBL] [Abstract][Full Text] [Related]
68. [Recommendation for Calcitonin Screening in Nodular Goiter]. Frank-Raue K; Schott M; Raue F; Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274 [TBL] [Abstract][Full Text] [Related]
69. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. Bugalho MJ; Santos JR; Sobrinho L J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359 [TBL] [Abstract][Full Text] [Related]
70. Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Essig GF; Porter K; Schneider D; Debora A; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas L; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT Endocr Pract; 2013; 19(6):920-7. PubMed ID: 23757627 [TBL] [Abstract][Full Text] [Related]
71. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse]. Łacka K; Michałek K; Majewski P Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567 [TBL] [Abstract][Full Text] [Related]
73. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822 [TBL] [Abstract][Full Text] [Related]